1. Home
  2. GH vs FG Comparison

GH vs FG Comparison

Compare GH & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GH
  • FG
  • Stock Information
  • Founded
  • GH 2011
  • FG 1959
  • Country
  • GH United States
  • FG United States
  • Employees
  • GH N/A
  • FG N/A
  • Industry
  • GH Medical Specialities
  • FG Life Insurance
  • Sector
  • GH Health Care
  • FG Finance
  • Exchange
  • GH Nasdaq
  • FG Nasdaq
  • Market Cap
  • GH 4.9B
  • FG 4.3B
  • IPO Year
  • GH 2018
  • FG N/A
  • Fundamental
  • Price
  • GH $54.62
  • FG $34.37
  • Analyst Decision
  • GH Strong Buy
  • FG Hold
  • Analyst Count
  • GH 17
  • FG 3
  • Target Price
  • GH $58.24
  • FG $44.33
  • AVG Volume (30 Days)
  • GH 2.4M
  • FG 144.9K
  • Earning Date
  • GH 11-05-2025
  • FG 11-05-2025
  • Dividend Yield
  • GH N/A
  • FG 2.55%
  • EPS Growth
  • GH N/A
  • FG N/A
  • EPS
  • GH N/A
  • FG 2.52
  • Revenue
  • GH $828,849,000.00
  • FG $5,309,000,000.00
  • Revenue This Year
  • GH $28.07
  • FG N/A
  • Revenue Next Year
  • GH $21.61
  • FG $19.65
  • P/E Ratio
  • GH N/A
  • FG $13.71
  • Revenue Growth
  • GH 28.74
  • FG 1.86
  • 52 Week Low
  • GH $20.14
  • FG $30.01
  • 52 Week High
  • GH $68.00
  • FG $50.75
  • Technical
  • Relative Strength Index (RSI)
  • GH 41.10
  • FG 51.69
  • Support Level
  • GH $53.67
  • FG $34.01
  • Resistance Level
  • GH $61.95
  • FG $34.95
  • Average True Range (ATR)
  • GH 2.29
  • FG 0.66
  • MACD
  • GH -1.51
  • FG -0.13
  • Stochastic Oscillator
  • GH 7.33
  • FG 30.77

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About FG F&G Annuities & Life Inc.

F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.

Share on Social Networks: